These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2526370

  • 1. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.
    Powell JS, Clozel JP, Müller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR.
    Science; 1989 Jul 14; 245(4914):186-8. PubMed ID: 2526370
    [Abstract] [Full Text] [Related]

  • 2. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition.
    Powell JS, Müller RK, Rouge M, Kuhn H, Hefti F, Baumgartner HR.
    J Cardiovasc Pharmacol; 1990 Jul 14; 16 Suppl 4():S42-9. PubMed ID: 1705627
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries.
    Fingerle J, Müller RM, Kuhn H, Pech M, Baumgartner HR.
    Arterioscler Thromb Vasc Biol; 1995 Nov 14; 15(11):1945-50. PubMed ID: 7583575
    [Abstract] [Full Text] [Related]

  • 4. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells.
    Powell JS, Rouge M, Müller RK, Baumgartner HR.
    Basic Res Cardiol; 1991 Nov 14; 86 Suppl 1():65-74. PubMed ID: 1827985
    [Abstract] [Full Text] [Related]

  • 5. Prevention of neointima formation by mibefradil after vascular injury in rats: comparison with ACE inhibition.
    Schmitt R, Clozel JP, Iberg N, Bühler FR.
    Cardiovasc Drugs Ther; 1996 May 14; 10(2):101-5. PubMed ID: 8842500
    [Abstract] [Full Text] [Related]

  • 6. Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors.
    Powell JS, Muller RK, Baumgartner HR.
    J Am Coll Cardiol; 1991 May 14; 17(6 Suppl B):137B-142B. PubMed ID: 1826694
    [Abstract] [Full Text] [Related]

  • 7. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.
    Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker LA.
    Hypertension; 1991 Oct 14; 18(4 Suppl):II70-6. PubMed ID: 1833327
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vascular protection with cilazapril.
    Clozel JP, Powell JS, Kuhn H, Müller RK, Hefti F, Baumgartner HR.
    Drugs; 1991 Oct 14; 41 Suppl 1():62-7. PubMed ID: 1712274
    [Abstract] [Full Text] [Related]

  • 16. Kinins and the events influenced by an angiotensin-converting enzyme inhibitor during neointima formation in the rat carotid artery.
    Farhy RD, Peterson E, Scicli AG.
    J Hypertens; 1997 Apr 14; 15(4):421-9. PubMed ID: 9211177
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat.
    Cook NS, Zerwes HG, Pally C, Rudin M, Hof RP.
    Blood Press; 1993 Dec 14; 2(4):322-31. PubMed ID: 8173703
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.